Characterization of adherence and persistence profile in a real‐life population of patients treated with adalimumab

Aims Published data on long‐term adherence and persistence with adalimumab (Humira®) in clinical practice are scarce and often limited to selected patient populations. This study assessed adherence with adalimumab across different indications and identified correlates and outcomes of poor adherence.